跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,469 条关于
“BRAVE-AA1”
全部
1,469
临床试验
885
药物
436
机构
2
资讯
146
去年
FDA Approves Baricitinib as First Systemic Treatment for Severe Alopecia Areata Based on Phase 3 Trial Results
去年
Baricitinib Shows Promising Hair Regrowth Results in Adolescents with Severe Alopecia Areata in Phase 3 Trial
去年
Biogen Launches Phase 3 Pediatric Trial of Omaveloxolone for Friedreich Ataxia
去年
Deuruxolitinib Demonstrates Efficacy in Hair Regrowth and Improves Patient Well-being in Severe Alopecia Areata
8个月前
European Regulators Recommend Olumiant for Adolescent Alopecia Areata Treatment
3个月前
Circadian Timing of Immunotherapy May Influence Outcomes in Triple-Negative Breast Cancer Based on Tumor Immune Microenvironment
去年
Sun Pharma Launches Deuruxolitinib for Severe Alopecia Areata in US Market
去年
FDA Approval of Leqselvi Marks Major Advancement in Severe Alopecia Areata Treatment
2年前
FDA Approves Leqselvi (Deuruxolitinib) for Severe Alopecia Areata
去年
Deuruxolitinib Shows Promise in Treating Alopecia Areata
第 1 页,共 15 页
上一页
下一页